Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China Is Top International Priority For AdvaMed's New Chairman

This article was originally published in The Gray Sheet

Executive Summary

AdvaMed's new chairman, Jim Mazzo, cites regulatory roadblocks in China as the most important international marketing issue facing U.S. device manufacturers

You may also be interested in...



Despite Reg Challenges, China Market Access Gradually Improving

China's regulatory environment remains a struggle for device firms seeking to gain marketing or manufacturing footholds in the country, but meaningful government efforts to improve the business climate are making a dent, suggest device executives who are focused on the region

Despite Reg Challenges, China Market Access Gradually Improving

China’s regulatory environment remains a struggle for device firms seeking to gain marketing or manufacturing footholds in the country, but meaningful government efforts to improve the business climate are making a dent, suggest device executives who are focused on the region.

Despite Reg Challenges, China Market Access Gradually Improving

China’s regulatory environment remains a struggle for device firms seeking to gain marketing or manufacturing footholds in the country, but meaningful government efforts to improve the business climate are making a dent, suggest device executives who are focused on the region.

Related Content

Topics

UsernamePublicRestriction

Register

OM007466

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel